Definitive Contract HHSN272201300025C
Award Date 9/30/13
Potential Completion Date 9/29/14
Potential Value $224K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Basking Ridge, Bernards, NJ, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Pulmokine, Inc. for the development of "Aerosolized Delivery of Anti-Tubercular Drugs." The contract has a ceiling value of $224,960.00 and a period of performance ending on January 15, 2016. As an SBIR Phase I contract, this award supports early-stage research and...
- This federal contract award, valued at $210,507.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to PAI Life Sciences Inc., a self-certified small disadvantaged business, for the "AEROSOLIZED DELIVERY OF ANTI-TUBERCULAR DRUGS" project. The contract is a Definitive Contract with a Firm Fixed Price pricing type. PAI Life Sciences will be the prime contractor, and Research Triangle Institute (RTI International), a non-profit research organization, will...
- This is a Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services, to Metallopharm LLC, a small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract, valued at $224,868.00, is for the development of a formulation for the oral delivery of the antibiotic Capreomycin. The contract has a firm fixed price pricing type and a total small...
- This is a $249,490.00 Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Strategic Drug Solutions, Inc., a small, minority-owned, and Asian-Pacific American-owned business. The contract is for the SBIR Program Phase I research and development of "Efficacy of Oral Aminoglycoside-Cochleate Formulations," with a place of performance in Chino Hills, California. The contract was...
- This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Qrumpharma, Inc., a self-certified small disadvantaged business, for a Small Business Innovation Research (SBIR) Program Phase I project. The objective is to determine the feasibility of a clofazimine inhalation formulation for preclinical development in tuberculosis. The contract is a definitive contract with a firm...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The award, valued at $14,994, is for the delivery of 5,400 crude peptides by A & A LABS LLC, also doing business as Synthetic Biomolecules. The contract does not have a set-aside designation. A & A LABS LLC is a minority-owned, small disadvantaged business. This contract award may support NIAID's...
- This is a firm fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute in Seattle, Washington. The contract is for in vitro characterization of anti-mycobacterial activity, as part of the larger In Vitro Antimicrobial Assessments 2011-2018 contract vehicle. The contract has a ceiling value of...
- <p>This is a $225,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Windtree Therapeutics, Inc. under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of a "K4L SURFACTANT AEROSOL TO REDUCE INFLUENZA LUNG INJURY" and has an ultimate completion date of December 31, 2016. The contract is designated as a Total Small Business set-aside.</p>
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to AAT Bioquest, Inc., a minority-owned, for-profit, woman-owned small business, and Asian-Pacific American-owned manufacturer of goods. The contract, valued at $161,032.00, is for products or services related to the NIH's mission of accelerating the translation of research to improve human health. The contract does not have a set-aside designation and...